
Glimicord MP 2mg/500mg/15mg Tablet
Marketer
Cordial Lifesciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimicord MP 2mg/500mg/15mg Tablet
Metformin/glimepiride/pioglitazone tablets (2mg/500mg/15mg) are a triple-combination medication managing blood glucose. Used alongside diet and exercise, it improves glycemic control in adult type 2 diabetics by enhancing insulin effectiveness, thus reducing blood sugar. Adhere strictly to your physician's prescribed dosage and regimen. Take with food to minimize gastrointestinal distress. For missed doses, take immediately unless nearing the next scheduled dose; in that case, omit the missed dose and resume your normal schedule. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concomitant use with other antidiabetics, alcohol consumption, or skipped meals elevates hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require physician consultation. Kidney function tests are mandatory before initiating this medication. Limit alcohol consumption to mitigate potential side effects.
Uses of Glimicord MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Glimicord MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimicord MP 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Glimicord MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimicord MP 2mg/500mg/15mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimicord MP 2mg/500mg/15mg Tablet should be administered with a meal.
How Glimicord MP 2mg/500mg/15mg Tablet works:
Glimicord MP 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three antidiabetic agents with complementary actions. This triple combination improves blood sugar management when single or dual drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Glimicord MP 2mg/500mg/15mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Glimicord MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Glimicord MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Preliminary evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if you experience such symptoms.
KidneyCAUTION
Exercise caution when prescribing Glimicord MP 2mg/500mg/15mg tablets to individuals with impaired renal function; dosage modification may be necessary. Patients with severe kidney disease should not receive this medication. Close monitoring of kidney function is recommended during treatment. Consult a physician for guidance.
LiverCAUTION
Patients with liver impairment should use Glimicord MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. This medication is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Glimicord MP 2mg/500mg/15mg Tablet :
Should you forget a Glimicord MP 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimicord MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
